Visit additional Tabor Communication Publications
May 17, 2012
AUSTIN, TX, May 17 -- The childhood cancer research computing cluster created and donated by Dell for the Translational Genomics Research Institute (TGen) is ready to support the world’s first precision medicine clinical trial for pediatric cancer. The computation performance of the cluster is expected to accelerate analysis and identification of targeted treatments beyond initial projections.
Oncologists from the Neuroblastoma and Medulloblastoma Translational Research Consortium (NMTRC) and biomedical researchers from TGen will use the new high performance computing and collaboration cloud to identify targeted treatments for pediatric cancer patients based on the specific genetic vulnerabilities of each child’s tumor—an approach that could be used to treat many pediatric and adult cancers in the future.
Dell’s team has completed the high performance computing cluster that will serve as the cloud’s computational foundation and basis for a private cloud. When equipped with Dell’s latest server technology—the PowerEdge M420 -- and a parallel approach to computation, TGen can analyze comprehensively a patient’s tumor RNA profile in one day versus the seven days that were previously required --an important advantage in the battle against aggressive childhood cancers. With the dedicated computing cluster in place, Dell will begin to connect the biomedical researchers sequencing and analyzing patient tumors at TGen in Arizona with oncologists providing treatment to patients participating in the trial at 11 medical centers. The new cloud will eliminate the need to express mail hard drives containing tumor and diagnostic images and genomic sequencing data between locations.
There has been only one new treatment for pediatric cancer approved by the FDA since the 1980s, compared with 50 treatments approved for adult cancer in this same timeframe. As a result, pediatric oncologists have relied upon treatments designed for adults, with toxic side effects that are frequently as physically detrimental to the child as the cancer itself. Precision medicine can overcome these barriers with treatments that target the specific vulnerabilities of each child’s tumor, leaving healthy cells untouched.
In related news, the NMTRC welcomed Dell Children’s Medical Center in Austin, Texas, to its membership and the list of hospitals participating in the clinical trial as it continues to expand medical center participation in the US and globally. And Ronald McDonald House Charities announced Dell’s contribution of $100,000 to support Ronald McDonald houses in 14 cities and the families who rely upon them when they are away from home for treatment.
Dell’s donations of cloud computing to TGen for the precision medicine clinical trial and funds to Ronald McDonald House Charities are part of the company’s multiyear, multimillion dollar commitment of technology, funding and employee engagement to improve childhood cancer treatment globally.
“There is no time to waste for children and families battling aggressive and deadly cancers like neuroblastoma,” said James Coffin, Ph.D., vice president and general manager, Dell Healthcare and Life Sciences. “That’s why Dell is focused on driving results faster—faster than our initial projections--for TGen and NMTRC so that they accelerate time-to-targeted treatment for children participating in the clinical trial and can open participation to more children over time.”
“This conference provides a great opportunity for researchers, clinicians and families to assess the state of pediatric cancer care today,” said Dr. Jeffrey Trent, TGen’s President and Research Director. “The collaborative model behind this conference is a great example of how through partnerships we can positively move research and treatment forward at a pace not seen before.”
“On behalf of the NMTRC, we are incredibly thankful for Dell’s support and expertise to help in the care of our patients,” said Giselle Sholler, Co-Director of the Pediatric Oncology Translational Research Program at the Van Andel Institute. “This meeting will bring together the top physicians, researchers and parent advocates working collaboratively to accelerate the search for a cure.”
Dell Inc. (NASDAQ: DELL) listens to customers and delivers innovative technology and services that give them the power to do more. Dell’s Powering the Possible program is funded by the company’s pledge to contribute 1 percent of its pre-tax profits to learning, pediatric cancer, innovative social entrepreneurship and disaster relief initiatives that address unmet needs globally and enable human potential. Information about Dell Powering the Possible is available at www.dell.com/pediactriccancer.
As the leading provider of healthcare IT services in the world, Dell helps healthcare organizations harness the power of information to simplify administration; coordinate and manage patient care; transition from episodic care to prevention and wellness management and ultimately to deliver personalized medicine.
The Translational Genomics Research Institute (TGen) is a Phoenix, Arizona-based non-profit organization dedicated to conducting groundbreaking research for life changing results. Research at TGen is focused on helping patients with diseases such as cancer, neurological disorders and diabetes. TGen is on the cutting edge of translational research where investigators are able to unravel the genetic components of common and complex diseases. Working with collaborators in the scientific and medical communities, TGen believes it can make a substantial contribution to the efficiency and effectiveness of the translational process. TGen is affiliated with the Van Andel Research Institute in Grand Rapids, Michigan. For more information, visit: www.tgen.org.
About the Neuroblastoma and Medulloblastoma Translational Research Consortium
Founded in 2008, the NMTRC is a nationwide network of childhood cancer trials based at the Van Andel Research Institute and chaired by Dr. Giselle Sholler. The consortium includes the following clinical partners: Cardinal Glennon Children’s Medical Center, Saint Louis University School of Medicine; Center for Children’s Cancer and Blood Disorders at Arnold Palmer Hospital for Children, MD Anderson Cancer Center Orlando; Children’s Mercy Hospitals and Clinics; Connecticut Children’s Medical Center; Doernbecher Children’s Hospital, Oregon Health & Science University; Helen DeVos Children’s Hospital; Levine Children’s Hospital; Medical University of South Carolina; National Cancer Institute; Rady Children’s Hospital San Diego, UCSD School of Medicine and the University of Hawaii Cancer Center.
Contributing commentator, Andrew Jones, offers a break in the news cycle with an assessment of what the national "size matters" contest means for the U.S. and other nations...
Today at the International Supercomputing Conference in Leipzing, Germany, Jack Dongarra presented on a proposed benchmark that could carry a bit more weight than its older Linpack companion. The high performance conjugate gradient (HPCG) concept takes into account new architectures for new applications, while shedding the floating point....
Not content to let the Tianhe-2 announcement ride alone, Intel rolled out a series of announcements around its Knights Corner and Xeon Phi products--all of which are aimed at adding some options and variety for a wider base of potential users across the HPC spectrum. Today at the International Supercomputing Conference, the company's Raj....
Jun 18, 2013 |
The world's largest supercomputers, like Tianhe-2, are great at traditional, compute-intensive HPC workloads, such as simulating atomic decay or modeling tornados. But data-intensive applications--such as mining big data sets for connections--is a different sort of workload, and runs best on a different sort of computer.
Jun 18, 2013 |
Researchers are finding innovative uses for Gordon, the 285 teraflop supercomputer housed at the San Diego Supercomputer Center (SDSC) that has a unique Flash-based storage system. Since going online, researchers have put the incredibly fast I/O to use on a wide variety of workloads, ranging from chemistry to political science.
Jun 17, 2013 |
The advent of low-power mobile processors and cloud delivery models is changing the economics of computing. But just as an economy car is good at different things than a full size truck, an HPC workload still has certain computing demands that neither the fastest smartphone nor the most elastic cloud cluster can fulfill.
Jun 14, 2013 |
For all the progress we've made in IT over the last 50 years, there's one area of life that has steadfastly eluded the grasp of computers: understanding human language. Now, researchers at the Texas Advanced Computing Center (TACC) are utilizing a Hadoop cluster on its Longhorn supercomputer to move the state of the art of language processing a little bit further.
Jun 13, 2013 |
Titan, the Cray XK7 at the Oak Ridge National Lab that debuted last fall as the fastest supercomputer in the world with 17.59 petaflops of sustained computing power, will rely on its previous LINPACK test for the upcoming edition of the Top 500 list.
05/10/2013 | Cleversafe, Cray, DDN, NetApp, & Panasas | From Wall Street to Hollywood, drug discovery to homeland security, companies and organizations of all sizes and stripes are coming face to face with the challenges – and opportunities – afforded by Big Data. Before anyone can utilize these extraordinary data repositories, however, they must first harness and manage their data stores, and do so utilizing technologies that underscore affordability, security, and scalability.
04/15/2013 | Bull | “50% of HPC users say their largest jobs scale to 120 cores or less.” How about yours? Are your codes ready to take advantage of today’s and tomorrow’s ultra-parallel HPC systems? Download this White Paper by Analysts Intersect360 Research to see what Bull and Intel’s Center for Excellence in Parallel Programming can do for your codes.
Join HPCwire Editor Nicole Hemsoth and Dr. David Bader from Georgia Tech as they take center stage on opening night at Atlanta's first Big Data Kick Off Week, filmed in front of a live audience. Nicole and David look at the evolution of HPC, today's big data challenges, discuss real world solutions, and reveal their predictions. Exactly what does the future holds for HPC?
Join our webinar to learn how IT managers can migrate to a more resilient, flexible and scalable solution that grows with the data center. Mellanox VMS is future-proof, efficient and brings significant CAPEX and OPEX savings. The VMS is available today.